InvestorsHub on MSN
Moleculin shares rise 6% as enrollment nears key milestone in AML trial
Moleculin Biotech Inc. (NASDAQ:MBRX) moved higher in premarket trading on Tuesday, gaining 6.2% after the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback